Study of ARQ 197 Monotherapy
NCT01152645
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
ARQ 197
Sponsor
Kyowa Kirin Co., Ltd.